Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

Part of paid clinical trials in Knoxville, Tennessee.

Sponsor
University of Tennessee Graduate School of Medicine
Study ID
NCT06802861
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Complications
  • Gestational Diabetes
  • Gestational Diabetes Mellitus in Pregnancy
  • Obesity and Obesity-related Medical Conditions
  • Preeclampsia
  • Preeclampsia (PE)
  • Preeclampsia (PE) Risk
  • Pregnancy
  • Pregnancy Complications

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Not accepted

Study Details

This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.

Key Dates

Start date
Jan 1, 2025
Status verified
Jan 2025
Primary completion
Jul 31, 2026
Completion
Dec 31, 2028

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Pregnant individuals at risk for preecampsia

Primary Outcome Measure

Hexadecadienoate (z score) [ Time Frame: 60 minutes after ingestion of 75 grams of glucose during a single study visit between 14-20 weeks gestational age ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Tennessee Medical CenterKnoxvilleTennessee37920
Rebecca Purvis, MD
[email protected]

Find similar trials in Knoxville, TN

By research site
University of Tennessee Medical Center· Knoxville, TN

Related Studies